Kanupriya Whig

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

Mark Dittmar, Jae Seung Lee, Kanupriya Whig et al. · Cell Reports · 2021 · 250 citations · Full text

Medicine, Pharmacology, Drug Discovery +12

Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2

D. Schultz, Robert M. Johnson, Kasirajan Ayyanathan et al. · Nature · 2022 · 200 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Pharmacological activation of STING blocks SARS-CoV-2 infection

Minghua Li, Max Ferretti, Baoling Ying et al. · Science Immunology · 2021 · 192 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer

Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi et al. · Cancer Discovery · 2022 · 98 citations · Full text

Life Sciences, Immunology, Oncology +16

Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2

Mark Dittmar, Jae Seung Lee, Kanupriya Whig et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 47 citations · Full text

Medicine, Infectious Diseases, Pharmacology +10